Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity?

Journal of Chemotherapy

Volumn 26, Issue 3, 2014, Pages 130-132

  Noto, Antonio ^a   Mussap, Michele ^b   Fanos, Vassilios ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Aminoglycosides; Antibiotics; Metabolomics; Neonatal sepsis; Renal toxicity

Indexed keywords

ADENOSINE; ALANINE; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; GLUTATHIONE; HYPOXANTHINE; PHOSPHATIDYLSERINE; PHOSPHOETHANOLAMINE; PROLINE; SPHINGOMYELIN; URACIL; URIC ACID; ANTIINFECTIVE AGENT;

ACUTE LUNG INJURY; BACTERIAL PNEUMONIA; DRUG DISTRIBUTION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY INJURY; LIVER TOXICITY; LUNG LAVAGE; METABOLOMICS; NEONATOLOGIST; NEPHROTOXICITY; NEWBORN MORBIDITY; NEWBORN SEPSIS; NONHUMAN; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEPTICEMIA; TIME OF FLIGHT MASS SPECTROMETRY; TISSUE INJURY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VIRAL BRONCHIOLITIS; INFANT, NEWBORN, DISEASES; METABOLISM; NEWBORN; PROCEDURES; SEPSIS; TRENDS;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; METABOLOMICS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SEPSIS;

EID: 84900333044     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000149     Document Type: Review

References (24)

1. Mussap M, Fanos V. Neonatal nephrology and laboratory medicine: an effective interdisciplinary model to improve the outcome in neonatal intensive care unit. J Matern Fetal Neonatal Med. 2011;24(Suppl 2):1-2.
2. Mussap M, Degrandi R, Cataldi L, Fanos V, Plebani M. Biochemical markers for the early assessment of neonatal sepsis: the role of procalcitonin. J Chemother. 2007;19(Suppl 2):35-8.
3. Mussap M, Cataldi L, Plebani M, Fanos V. Laboratory investigation for the early diagnosis and monitoring of neonatal urinary tract infections: the present situation and future perspectives. J Chemother. 2006;18(Spec no 3):9-13.
4. Fanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in neonatology and pediatrics. Clin Biochem. 2011;44:452-4.
5. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455:1054-6.
6. Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn Reson. 2000;12:289-20.
7. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-71.
8. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011;40(1):387-426.
9. Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med. 2009;22(Suppl 3):50-3.
10. Fanos V, Barberini L, Antonucci R, Atzori L. Pharmametabolomics in neonatology: is it a dream or a fact? Curr Pharm Des. 2012;21:2996-3006.
11. Liu X-R, Zheng X-F, Ji S-Z, Lv Y-H, Zheng D-Y, Xia Z-F, et al. Metabolomic analysis of thermally injured and/or septic rats. Burns. 2010;36(7):992-8.
12. Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L4-11.
13. Izquierdo-García JL, Nin N, Ruíz-Cabello J, Rojas Y, de Paula M, López-Cuenca S, et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med. 2011; 37:2023-32.
14. Atzei A, Atzori L, Moretti C, Barberini L, Noto A, Ottonello G, et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. JMatern Fetal NeonatalMed. 2011;(24 (Suppl 2):59-62.
15. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, Charles PGP, et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res. 2009; 8(12):5550-8.
16. Lindon JC, Holmes E, Nicholson JK. Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res. 2006;23(6):1075-88.
17. Atzori L, Griffin JL, Noto A, Fanos V. Metabolomics: a new approach to drug delivery in perinatology. Curr Med Chem. 2012;19(27):4654-61.
18. Antonucci R, Atzori L, Barberini L, Fanos V. Metabolomics: the 'new clinical chemistry' for personalized neonatal medicine. Minerva Pediatr. 2010;62:145-8.
19. Hanna MH, Segar JL, Teesch LM, Kasper DC, Schaefer FS, Brophy PD. Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats. Pediatr Res. 2013;73(5):585-91.
20. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010;28(5):436-40.
21. Atzori L, Antonucci R, Barberini L, Locci E, CesareMarincola F, Scano P, et al. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed). 2010;2:725-32.
22. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez- Hernandez FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2011;79(1):33-45.
23. Boudonck KJ, Mitchell MW, Német L, Keresztes L, Nyska A, Shinar D, et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol. 2009;37(3): 280-92.
24. Tzovaras V, Tsimihodimos V, Kostara C, Mitrogianni Z, Elisaf M. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine. Nephrol Dial Transplant. 2011;26(10):3219-24.